Please login to the form below

Not currently logged in
Email:
Password:

Albumedix appoints Dr Giles Campion as CMO

He brings experience from Novartis and BioMarin

Albumedix Dr Giles CampionCopenhagen, Denmark-based Albumedix has appointed Dr Giles Campion as its chief medical officer and member of the executive team.

Dr Campion will be responsible for the firm's global development efforts, with a particular focus on its albumin-based drug delivery platform.

He brings over 25 years of drug development experience to the role, most recently as group vice president of BioMarin's neuromuscular franchise.

Prior to this, Dr Campion was both senior vice president of R&D and chief medical officer of Prosensa Holdings, served as global head of clinical R&D at General Electric Healthcare, and was European head of exploratory clinical development at Novartis.

Peter Rosholm, chief executive of Albumedix, said: “I am delighted to welcome Giles Campion to Albumedix.

“His depth of experience across a broad range of therapeutic indications, drug development track record and expertise in the filings of specialised pharmaceuticals, will be invaluable to us as we move our pre-clinical drug candidates towards the clinic.

“The appointment marks the latest step in our growth strategy as we work to advance breakthroughs in the use of albumin-based technologies in the development of life-changing therapeutics.”

16th January 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics